Universal cholesterol screening of children in community-based ambulatory pediatric clinics

Don P. Wilson, Sharon Davis, Sarah Matches, Deep Shah, Van Leung-Pineda, Margaret Mou, Luke Hamilton, Catherine J. McNeal, W. Paul Bowman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background Early identification and treatment of individuals with elevated levels of atherogenic cholesterol have been shown to be effective and safe in reducing morbidity and mortality, especially in familial hypercholesterolemia. To better inform providers and identify children and adolescents at risk of premature cardiovascular disease, in November 2011, the National Heart, Lung, and Blood Institute (NHLBI) published guidelines recommending cholesterol screening of all children aged between 9 to 11 and 17 to 21 years regardless of the child's general health or the presence or the absence of cardiovascular disease risk factors. Objective To compare the number of 9- to 11-year-old children screened for hypercholesterolemia in 5 community-based ambulatory pediatric clinics before and after publication of the NHLBI's guidelines. Methods Practice demographics, screening frequency, and test results for each clinic were collected before and after publication of the NHLBI's recommendation. Provider education was provided between measures. Results Of all eligible 9- to 11-year-old children, 489 (17.1%) were screened before and 686 (20.1%) after the NHLBI's guidelines and provider education. Conclusions Baseline rates of lipid screening for the 5 community-based ambulatory pediatric clinics were higher than those previously reported and increased significantly after publication of the NHLBI's recommendations and provider education. However, overall screening rates remained low. Given the high prevalence of premature cardiovascular disease associated with atherogenic cholesterol, especially familial hypercholesterolemia, additional strategies are needed to improve screening rates.

Original languageEnglish
Article number766
Pages (from-to)S88-S92
JournalJournal of Clinical Lipidology
Volume9
Issue number5
DOIs
StatePublished - 1 Sep 2015

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Cholesterol
Pediatrics
Publications
Hyperlipoproteinemia Type II
Cardiovascular Diseases
Guidelines
Education
Hypercholesterolemia
Demography
Morbidity
Lipids
Mortality

Keywords

  • Children
  • Cholesterol
  • Familial hypercholesterolemia
  • Guidelines
  • Universal screening

Cite this

Wilson, Don P. ; Davis, Sharon ; Matches, Sarah ; Shah, Deep ; Leung-Pineda, Van ; Mou, Margaret ; Hamilton, Luke ; McNeal, Catherine J. ; Bowman, W. Paul. / Universal cholesterol screening of children in community-based ambulatory pediatric clinics. In: Journal of Clinical Lipidology. 2015 ; Vol. 9, No. 5. pp. S88-S92.
@article{bdfeb7ee89984fe997f048ec509c637c,
title = "Universal cholesterol screening of children in community-based ambulatory pediatric clinics",
abstract = "Background Early identification and treatment of individuals with elevated levels of atherogenic cholesterol have been shown to be effective and safe in reducing morbidity and mortality, especially in familial hypercholesterolemia. To better inform providers and identify children and adolescents at risk of premature cardiovascular disease, in November 2011, the National Heart, Lung, and Blood Institute (NHLBI) published guidelines recommending cholesterol screening of all children aged between 9 to 11 and 17 to 21 years regardless of the child's general health or the presence or the absence of cardiovascular disease risk factors. Objective To compare the number of 9- to 11-year-old children screened for hypercholesterolemia in 5 community-based ambulatory pediatric clinics before and after publication of the NHLBI's guidelines. Methods Practice demographics, screening frequency, and test results for each clinic were collected before and after publication of the NHLBI's recommendation. Provider education was provided between measures. Results Of all eligible 9- to 11-year-old children, 489 (17.1{\%}) were screened before and 686 (20.1{\%}) after the NHLBI's guidelines and provider education. Conclusions Baseline rates of lipid screening for the 5 community-based ambulatory pediatric clinics were higher than those previously reported and increased significantly after publication of the NHLBI's recommendations and provider education. However, overall screening rates remained low. Given the high prevalence of premature cardiovascular disease associated with atherogenic cholesterol, especially familial hypercholesterolemia, additional strategies are needed to improve screening rates.",
keywords = "Children, Cholesterol, Familial hypercholesterolemia, Guidelines, Universal screening",
author = "Wilson, {Don P.} and Sharon Davis and Sarah Matches and Deep Shah and Van Leung-Pineda and Margaret Mou and Luke Hamilton and McNeal, {Catherine J.} and Bowman, {W. Paul}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.jacl.2015.05.006",
language = "English",
volume = "9",
pages = "S88--S92",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "5",

}

Universal cholesterol screening of children in community-based ambulatory pediatric clinics. / Wilson, Don P.; Davis, Sharon; Matches, Sarah; Shah, Deep; Leung-Pineda, Van; Mou, Margaret; Hamilton, Luke; McNeal, Catherine J.; Bowman, W. Paul.

In: Journal of Clinical Lipidology, Vol. 9, No. 5, 766, 01.09.2015, p. S88-S92.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Universal cholesterol screening of children in community-based ambulatory pediatric clinics

AU - Wilson, Don P.

AU - Davis, Sharon

AU - Matches, Sarah

AU - Shah, Deep

AU - Leung-Pineda, Van

AU - Mou, Margaret

AU - Hamilton, Luke

AU - McNeal, Catherine J.

AU - Bowman, W. Paul

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background Early identification and treatment of individuals with elevated levels of atherogenic cholesterol have been shown to be effective and safe in reducing morbidity and mortality, especially in familial hypercholesterolemia. To better inform providers and identify children and adolescents at risk of premature cardiovascular disease, in November 2011, the National Heart, Lung, and Blood Institute (NHLBI) published guidelines recommending cholesterol screening of all children aged between 9 to 11 and 17 to 21 years regardless of the child's general health or the presence or the absence of cardiovascular disease risk factors. Objective To compare the number of 9- to 11-year-old children screened for hypercholesterolemia in 5 community-based ambulatory pediatric clinics before and after publication of the NHLBI's guidelines. Methods Practice demographics, screening frequency, and test results for each clinic were collected before and after publication of the NHLBI's recommendation. Provider education was provided between measures. Results Of all eligible 9- to 11-year-old children, 489 (17.1%) were screened before and 686 (20.1%) after the NHLBI's guidelines and provider education. Conclusions Baseline rates of lipid screening for the 5 community-based ambulatory pediatric clinics were higher than those previously reported and increased significantly after publication of the NHLBI's recommendations and provider education. However, overall screening rates remained low. Given the high prevalence of premature cardiovascular disease associated with atherogenic cholesterol, especially familial hypercholesterolemia, additional strategies are needed to improve screening rates.

AB - Background Early identification and treatment of individuals with elevated levels of atherogenic cholesterol have been shown to be effective and safe in reducing morbidity and mortality, especially in familial hypercholesterolemia. To better inform providers and identify children and adolescents at risk of premature cardiovascular disease, in November 2011, the National Heart, Lung, and Blood Institute (NHLBI) published guidelines recommending cholesterol screening of all children aged between 9 to 11 and 17 to 21 years regardless of the child's general health or the presence or the absence of cardiovascular disease risk factors. Objective To compare the number of 9- to 11-year-old children screened for hypercholesterolemia in 5 community-based ambulatory pediatric clinics before and after publication of the NHLBI's guidelines. Methods Practice demographics, screening frequency, and test results for each clinic were collected before and after publication of the NHLBI's recommendation. Provider education was provided between measures. Results Of all eligible 9- to 11-year-old children, 489 (17.1%) were screened before and 686 (20.1%) after the NHLBI's guidelines and provider education. Conclusions Baseline rates of lipid screening for the 5 community-based ambulatory pediatric clinics were higher than those previously reported and increased significantly after publication of the NHLBI's recommendations and provider education. However, overall screening rates remained low. Given the high prevalence of premature cardiovascular disease associated with atherogenic cholesterol, especially familial hypercholesterolemia, additional strategies are needed to improve screening rates.

KW - Children

KW - Cholesterol

KW - Familial hypercholesterolemia

KW - Guidelines

KW - Universal screening

UR - http://www.scopus.com/inward/record.url?scp=84940956139&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2015.05.006

DO - 10.1016/j.jacl.2015.05.006

M3 - Article

C2 - 26343216

AN - SCOPUS:84940956139

VL - 9

SP - S88-S92

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

SN - 1933-2874

IS - 5

M1 - 766

ER -